Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
10908 search results for:

Parathyroid Cancer 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. Open Access 20-03-2024 | Hypoparathyroidism | Online First

    Evaluating the effectiveness of dual dye combination of indocyanine green and carbon nanoparticles with parathyroid hormone test in preserving parathyroid gland during papillary thyroid cancer surgery: a single-center retrospective cohort study

    Preserving the integrity of parathyroid glands is crucial in papillary thyroid cancer (PTC) surgery to avoid hypoparathyroidism. In recent years, two novel dyes, activated carbon nanoparticles (CNP) and indocyanine green (ICG), have been utilized …

    Author:
    Yuliang Chen, Songze Zhang, Keyu Miao, Jiagen Li
    Published in:
    Updates in Surgery
  2. 25-05-2023 | Bisphosphonate | OriginalPaper

    Granulocyte-colony stimulating factor producing cervical cancer with elevated levels of parathyroid hormone-related protein: a case report and literature review

    Systemic effects associated with hormones and cytokines secreted by tumor cells can cause paraneoplastic syndrome. Leukemoid reactions and hypercalcemia are relatively common manifestations of paraneoplastic syndrome. Here, we describe the case of …

    Author:
    Naoya Matsuoka, Takayuki Katsuno, Genri Tagami, Koki Ishizuka, Toyonori Tsuzuki, Yasuhiko Ito
    Published in:
    CEN Case Reports > Issue: 1 / 2024
  3. Open Access 01-12-2023 | Hyperparathyroidism | OriginalPaper

    Investigating the risk of metabolic and cardiovascular comorbidities among patients with parathyroid cancer: a nationwide representative cohort study in Taiwan

    Parathyroid cancer is a rare malignant endocrine neoplasm that occurs in one case per 10 million people in the USA [ 1 ] but has shown increasing incidence in the last few decades [ 2 ]. Parathyroid cancer accounts for 0.005% of all cancers and the …

    Author:
    Ming-Chieh Tsai, Min-Shu Hsu, Hsin-Yin Hsu, Tzu-Lin Yeh, Chun-Ju Chiang, Wen-Chung Lee, Jing-Rong Jhuang, Shih-Ping Cheng, Po-Jung Tseng, Kuo-Liong Chien
    Published in:
    BMC Medicine > Issue: 1 / 2023
  4. Open Access 01-12-2022 | Radiotherapy | OriginalPaper

    Parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor type 1 in locally advanced laryngeal cancer as prognostic indicators of relapse and survival

    Laryngeal squamous cell carcinoma remains one of the most common cancer of the respiratory tract. Although the overall incidence is declining and despite advances in multimodal therapy, the overall 5-year survival rate of patients with locally …

    Author:
    Giovanni Almadori, Antonella Coli, Eugenio De Corso, Dario Antonio Mele, Stefano Settimi, Giovanni Di Cintio, Francesca Brigato, Domenico Scannone, Libero Lauriola, Franco Oreste Ranelletti
    Published in:
    BMC Cancer > Issue: 1 / 2022
  5. Open Access 01-12-2021 | Rectal Cancer | OriginalPaper

    Severe hypercalcemia caused by parathyroid hormone in a rectal cancer metastasis: a case report

    Hypercalcemia of malignancy occurs in approximately 20–30% of all cancers [ 1 ], and is associated with poor prognosis. Thirty-day-mortality in cancer-related hypercalcemia can be as high as 50% [ 2 ]. Medical treatment may require hospitalization …

    Author:
    Vegard Heimly Brun, Erik Knutsen, Helge Stenvold, Hanne Halvorsen
    Published in:
    BMC Endocrine Disorders > Issue: 1 / 2021
  6. Open Access 01-12-2023 | Metastasis | OriginalPaper

    Evaluation of factors predicting postoperative recurrence and metastasis of parathyroid cancer: a single-center study

    Parathyroid carcinoma (PC) is a rare endocrine tumor accounting for 0.5–6% or less in cases of primary hyperparathyroidism [ 1 – 3 ]. Currently, the World Health Organization (WHO) histopathologic findings are the standard methods for diagnosing …

    Author:
    Keiko Ohkuwa, Ryohei Katoh, Kiminori Sugino, Mitsuji Nagahama, Wataru Kitagawa, Kenichi Matsuzu, Nobuhiro Fukunari, Koichi Ito
    Published in:
    World Journal of Surgical Oncology > Issue: 1 / 2023
  7. 01-11-2020 | Radioiodine Therapy | OriginalPaper

    The effects of radioiodine therapy on parathyroid function among patients with papillary thyroid cancer: a retrospective cohort study

    The incidence of thyroid carcinoma has increased dramatically in the last decades [ 1 ]. Papillary thyroid cancer (PTC) is the major histopathological type among thyroid malignancy [ 2 , 3 ]. At present, the treatment of PTC includes conservative …

    Author:
    Yuan Fei, Yuxuan Qiu, Zhichao Xing, Wanjun Zhao, Anping Su, Jingqiang Zhu
    Published in:
    Endocrine > Issue: 2 / 2020
  8. 01-10-2019 | Esophageal Cancer | OriginalPaper

    Thyroid and Parathyroid Functions After Pharyngo-Laryngo-Esophagectomy for Cervical Esophageal Cancer
    Author:
    Yoshiyuki Saito MD, PhD, Hirofumi Kawakubo MD, PhD, Hiroshi Takami MD, PhD, Junya Aoyama MD, Shuhei Mayanagi MD, PhD, Tomoyuki Irino MD, PhD, Kazumasa Fukuda MD, PhD, Koichi Suda MD, PhD, Rieko Nakamura MD, PhD, Norihito Wada MD, PhD, Yuko Kitagawa MD, PhD
    Published in:
    Annals of Surgical Oncology > Issue: 11 / 2019
  9. 01-05-2022 | Metastasis | OriginalPaper

    Mortality factors in recurrent parathyroid cancer: a pooled analysis

    Parathyroid carcinoma (PC) is a rare disease accounting for less than 1% of primary hyperparathyroidism (PHPT). There is no sex-specific bias in PC, in contrast to primary hyperparathyroidism, where there is a three-to-fourfold higher incidence …

    Author:
    Wen-Hsuan Tsai, Yi-Hong Zeng, Chun-Chuan Lee, Ming-Chieh Tsai
    Published in:
    Journal of Bone and Mineral Metabolism > Issue: 3 / 2022
  10. 01-01-2021 | Metastasis | OriginalPaper

    The Use and Benefit of Adjuvant Radiotherapy in Parathyroid Carcinoma: A National Cancer Database Analysis

    This study was designated as exempt by the Institutional Review Board at Weill Cornell Medicine, given the use of publicly available de-identified data from the American College of Surgeons National Cancer Database (NCDB). The NCDB is the largest …

    Author:
    Jessica Limberg MD, Dessislava Stefanova MD, Timothy M. Ullmann MD, Jessica W. Thiesmeyer MD, Sarina Bains MD, Toni Beninato MD, MS, Rasa Zarnegar MD, Thomas J. Fahey III MD, Brendan M. Finnerty MD
    Published in:
    Annals of Surgical Oncology > Issue: 1 / 2021
  11. 01-01-2020 | Parathyroid Cancer | OriginalPaper

    Long-term remission of disseminated parathyroid cancer following immunotherapy

    Parathyroid carcinoma is a rare malignancy encountered in less than 1% of patients with primary hyperparathyroidism (1°HPT) [ 1 – 4 ]. Patients with parathyroid carcinoma typically present with larger tumors and with higher PTH and calcium levels …

    Author:
    Marta Sarquis, Stephen J. Marx, Albert Beckers, Arthur R. Bradwell, William F. Simonds, Maria Aparecida C. Bicalho, Adrian F. Daly, Daniela Betea, Eitan Friedman, Luiz De Marco
    Published in:
    Endocrine > Issue: 1 / 2020
  12. 01-09-2016 | OriginalPaper

    Differentiating Atypical Parathyroid Neoplasm from Parathyroid Cancer

    Data prospectively collected between the years 2000 and 2014 were analyzed, and the patient population was identified through a search of the Tumor Registry Database maintained by the Department of Medical Informatics. Inclusion criteria included …

    Author:
    Ioannis Christakis MD, PhD, Naifa Bussaidy MD, Callisia Clarke MD, Lily Joy Kwatampora MD, Carla L. Warneke MD, Angelica M. Silva MD, Michelle D. Williams MD, Elizabeth Gardner Grubbs MD, Jeffrey E. Lee MD, Nancy D. Perrier MD, FACS
    Published in:
    Annals of Surgical Oncology > Issue: 9 / 2016
  13. 01-04-2018 | OriginalPaper

    Dual Pathologies of Parathyroid Adenoma and Papillary Thyroid Cancer on Fluorocholine and Fluorodeoxyglucose PET/CT

    18F-Fluorocholine (FCH) PET/CT is evolving as a functional imaging modality for the preoperative imaging of abnormal parathyroid tissue(s) helping to localize eutopic and ectopic parathyroid tissue and limit the extent of surgery. FCH PET/CT may …

    Author:
    N. T. K. Thanseer, Sanjay Kumar Bhadada, Ashwani Sood, Ashwin Singh Parihar, Divya Dahiya, Priyanka Singh, Rajender Kumar Basher, Ashim Das, Bhagwant R. Mittal
    Published in:
    Nuclear Medicine and Molecular Imaging > Issue: 2 / 2018
  14. 01-02-2018 | Erratum

    Erratum to: Dual Pathologies of Parathyroid Adenoma and Papillary Thyroid Cancer on Fluorocholine and Fluorodeoxyglucose PET/CT
    Author:
    N. T. K. Thanseer, Sanjay Kumar Bhadada, Ashwani Sood, Ashwin Singh Parihar, Divya Dahiya, Priyanka Singh, Rajender Kumar Basher, Ashim Das, Bhagwant R. Mittal
    Published in:
    Nuclear Medicine and Molecular Imaging > Issue: 1 / 2018
  15. 01-11-2017 | OriginalPaper

    Cinacalcet hydrochloride relieves hypercalcemia in Japanese patients with parathyroid cancer and intractable primary hyperparathyroidism

    Pharmacological treatment of hypercalcemia is essential for patients with parathyroid carcinoma and intractable primary hyperparathyroidism (PHPT). Use of the calcimimetic cinacalcet hydrochloride (cinacalcet) is an option to treat such patients.

    Author:
    Yasuhiro Takeuchi, Shunsuke Takahashi, Daishu Miura, Makoto Katagiri, Noriaki Nakashima, Hiroko Ohishi, Ryutaro Shimazaki, Yoshihiro Tominaga
    Published in:
    Journal of Bone and Mineral Metabolism > Issue: 6 / 2017
  16. 01-11-2007 | OriginalPaper

    Intra-operative Parathyroid Hormone Monitoring in Patients with Parathyroid Cancer

    Among 556 consecutive patients with SPHPT who underwent limited parathyroidectomy guided by IPM at the University of Miami between 1992 and 2005, eight patients had the histopathological diagnosis of parathyroid cancer. Patient demographics …

    Author:
    C. C. Solórzano MD, D. M. Carneiro-Pla MD, J. I. Lew MD, S. E. Rodgers MD, PhD, R Montano BS, G. L. Irvin III MD
    Published in:
    Annals of Surgical Oncology > Issue: 11 / 2007
  17. 01-02-2004 | Abstract

    The use of intraoperative parathyroid hormone assay (QPTH) in patients with parathyroid cancer
    Author:
    D. M. Carneiro, M. C. Ramirez, G. L. Irvin III, C. C. Solorzano
    Published in:
    Annals of Surgical Oncology > Issue: Special Issue 2 / 2004
  18. Open Access 01-06-2016 | BriefCommunication

    Detection of Synchronous Parathyroid Adenoma and Breast Cancer with 18F-Fluorocholine PET-CT
    Author:
    Wessel MCM Vorselaars, Wouter P. Kluijfhout, Menno R. Vriens, Carmen C. van der Pol, Inne HM Borel Rinkes, Gerlof D. Valk, Bart de Keizer
    Published in:
    Nuclear Medicine and Molecular Imaging > Issue: 2 / 2016
  19. 01-09-2011 | OriginalPaper

    Ultrasound features of malignancy in the preoperative diagnosis of parathyroid cancer: a retrospective analysis of parathyroid tumours larger than 15 mm

    Parathyroid cancer is rare [ 1 ]. In contrast primary hyperparathyroidism (pHPT) is seen with a life-time incidence of 0.5–4 per 1000 in Western countries [ 2 , 3 ], accounting for an annual volume of over 10,000 new cases worldwide [ 4 ]. A total …

    Author:
    Paul S. Sidhu, Nadia Talat, Preena Patel, Nicola J. Mulholland, Klaus-Martin Schulte
    Published in:
    European Radiology > Issue: 9 / 2011
  20. 01-05-2015 | OriginalPaper

    Parathyroid adenoma upstaging the lung cancer

    Mediastinal staging of NSCLC with noninvasive methods such as PET/CT can be misleading when a mediastinal disease accompany. Histopathologic confirmation should be made before any treatment plan. Herein, we presented a case of parathyroid adenoma …

    Author:
    Kursat Okuyucu, Kuthan Kavakli, Sukru Ozaydın, Serdar Karahatay, Okan Karatas, Deniz Doğan
    Published in:
    Annals of Nuclear Medicine > Issue: 4 / 2015

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.